Browse by UCL people
Group by: Type | Date
Jump to: Article
Number of items: 12.
Article
Borg, C;
Jahun, AS;
Thorne, L;
Sorgeloos, F;
Bailey, D;
Goodfellow, IG;
(2021)
Murine norovirus virulence factor 1 (VF1) protein contributes to viral fitness during persistent infection.
Journal of General Virology
, 102
(9)
, Article 001651. 10.1099/jgv.0.001651.
|
Dudas, G;
Carvalho, LM;
Bedford, T;
Tatem, AJ;
Baele, G;
Faria, NR;
Park, DJ;
... Rambaut, A; + view all
(2017)
Virus genomes reveal factors that spread and sustained the Ebola epidemic.
Nature
, 544
(7650)
pp. 309-315.
10.1038/nature22040.
|
Petrillo, C;
Thorne, LG;
Unali, G;
Schiroli, G;
Giordano, AMS;
Piras, F;
Cuccovillo, I;
... Kajaste-Rudnitski, A; + view all
(2018)
Cyclosporine H Overcomes Innate Immune Restrictions to Improve Lentiviral Transduction and Gene Editing In Human Hematopoietic Stem Cells.
Cell Stem Cell
, 23
pp. 1-13.
10.1016/j.stem.2018.10.008.
|
Sumner, RP;
Thorne, LG;
Fink, DL;
Khan, H;
Milne, RS;
Towers, GJ;
(2017)
Are evolution and the intracellular innate immune System Key Determinants in HIV Transmission?
Frontiers in Immunology
, 8
, Article 1246. 10.3389/fimmu.2017.01246.
|
Thorne, LG;
Bouhaddou, M;
Reuschl, AK;
Zuliani-Alvarez, L;
Polacco, B;
Pelin, A;
Batra, J;
... Krogan, NJ; + view all
(2022)
Evolution of enhanced innate immune evasion by SARS-CoV-2.
Nature
, 602
pp. 487-495.
10.1038/s41586-021-04352-y.
|
Thorne, Lucy G;
Bouhaddou, Mehdi;
Reuschl, Ann-Kathrin;
Zuliani-Alvarez, Lorena;
Polacco, Ben;
Pelin, Adrian;
Batra, Jyoti;
... Krogan, Nevan J; + view all
(2022)
Publisher Correction: Evolution of enhanced innate immune evasion by SARS-CoV-2.
Nature
10.1038/s41586-022-04653-w.
|
Thorne, L;
Lu, J;
Chaudhry, Y;
Bailey, D;
Goodfellow, I;
(2018)
Targeting macrophage- and intestinal epithelial cell-specific microRNAs against norovirus restricts replication in vivo.
Journal of General Virology
, 99
(12)
pp. 1621-1632.
10.1099/jgv.0.001065.
|
Thorne, L;
Lu, J;
Chaudhry, Y;
Goodfellow, I;
(2018)
miR-155 induction is a marker of murine norovirus infection but does not contribute to control of replication in vivo.
Wellcome Open Research
, 3
, Article 42. 10.12688/wellcomeopenres.14188.1.
|
Thorne, L;
Nalwoga, A;
Mentzer, AJ;
Rougemont, AD;
Hosmillo, M;
Webb, E;
Nampiija, M;
... Goodfellow, I; + view all
(2018)
The First Norovirus Longitudinal Seroepidemiological Study From Sub-Saharan Africa Reveals High Seroprevalence of Diverse Genotypes Associated With Host Susceptibility Factors.
The Journal of Infectious Diseases
, 218
(5)
pp. 716-725.
10.1093/infdis/jiy219.
|
Thorne, LG;
Reuschl, A-K;
Zuliani-Alvarez, L;
Whelan, MVX;
Turner, J;
Noursadeghi, M;
Jolly, C;
(2021)
SARS-CoV-2 sensing by RIG-I and MDA5 links epithelial infection to macrophage inflammation.
EMBO Journal
, Article e107826. 10.15252/embj.2021107826.
(In press).
|
Towers, GJ;
Khan, H;
Sumner, RP;
Rasaiyaah, J;
Tan, CP;
Rodriguez Plata, MT;
Van Tulleken, C;
... Milne, RSB; + view all
(2020)
HIV-1 Vpr antagonizes innate immune activation by targeting karyopherin-mediated NF- κB/IRF3 nuclear transport.
eLife
, 9
, Article e60821. 10.7554/eLife.60821.
(In press).
|
Varona, JF;
Landete, P;
Lopez-Martin, JA;
Estrada, V;
Paredes, R;
Guisado-Vasco, P;
Fernandez de Orueta, L;
... Garcia-Sastre, A; + view all
(2022)
Preclinical and randomized phase I studies of plitidepsin in adults hospitalized with COVID-19.
Life Science Alliance
, 5
(4)
, Article e202101200. 10.26508/lsa.202101200.
|